What is the recommended treatment for Acute Respiratory Distress Syndrome (ARDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Respiratory Distress Syndrome (ARDS)

The cornerstone of ARDS treatment is lung-protective mechanical ventilation using low tidal volumes (4-8 ml/kg of predicted body weight), low plateau pressures (≤30 cmH₂O), and appropriate PEEP, along with systemic corticosteroids for all ARDS patients. 1

Ventilation Strategies Based on ARDS Severity

ARDS severity is classified according to the PaO₂/FiO₂ ratio:

Severity PaO₂/FiO₂ Recommended Management
Mild 201-300 mmHg Lower PEEP (5-10 cmH₂O), target PaO₂ 70-90 mmHg
Moderate 101-200 mmHg Higher titrated PEEP, target PaO₂ 70-90 mmHg
Severe ≤100 mmHg Higher titrated PEEP, target PaO₂ 70-90 mmHg, prone positioning, consider neuromuscular blockade

Key Ventilation Principles:

  • Use low tidal volumes (4-8 ml/kg of predicted body weight) 1, 2
  • Maintain plateau pressure ≤30 cmH₂O 1, 3
  • Apply appropriate PEEP based on severity 1
  • Target PaO₂ 70-90 mmHg 1

Advanced Interventions for Moderate to Severe ARDS

Prone Positioning

  • Strongly recommended for severe ARDS (PaO₂/FiO₂ <150 mmHg) 1, 3
  • Implement early (within first 48 hours) 1
  • Maintain for 12-20 hours per day (ideally 16-20 hours) 1, 3

Neuromuscular Blocking Agents

  • Recommended for early severe ARDS (first 48 hours) 1
  • Benefits: prevents patient-ventilator dyssynchrony and excessive transpulmonary pressure 1
  • Consider cisatracurium for 48 hours for patients with PF ratios ≤20 kPa 3

Systemic Corticosteroids

  • Strongly recommended for all ARDS patients 1
  • Benefits: reduced inflammatory response, decreased pulmonary edema, improved survival 1

Fluid Management

  • Conservative fluid management strategy recommended 1, 3
  • Aim to minimize pulmonary edema while maintaining adequate organ perfusion 4

Extracorporeal Membrane Oxygenation (ECMO)

  • Consider for very severe ARDS when conventional strategies fail 3, 5
  • Used as an adjunct to protective mechanical ventilation 3

Supportive Care

  • DVT prophylaxis 1
  • Stress ulcer prophylaxis 1
  • Nutritional support 1
  • Regular assessment of sedation requirements 1

Weaning from Mechanical Ventilation

  • Daily assessment for weaning readiness 1
  • Use spontaneous breathing trials when ready 1
  • Follow structured weaning protocol to minimize failure risk 1

Common Pitfalls and How to Avoid Them

  1. Excessive tidal volumes or plateau pressures

    • Strictly adhere to lung-protective ventilation parameters
    • Monitor plateau pressures continuously
  2. Inadequate PEEP

    • Titrate PEEP based on severity and individual response
    • Aim to maximize alveolar recruitment while avoiding overdistention
  3. Delayed implementation of prone positioning

    • Implement early (within 48 hours) for severe ARDS
    • Maintain adequate duration (12-20 hours/day)
  4. Fluid overload

    • Implement conservative fluid strategy
    • Differentiate ARDS from cardiogenic pulmonary edema
  5. Ventilator-associated pneumonia

    • Implement VAP prevention bundle
    • Occurs in 9-27% of intubated patients 1
  6. Barotrauma and volutrauma

    • Strictly adhere to lung-protective ventilation
    • Monitor for signs of air leaks or pneumothorax
  7. Delayed recognition of weaning readiness

    • Perform daily assessments
    • Use standardized protocols for weaning

Special Considerations

Pregnancy

  • Decreased functional residual capacity by 10-25%
  • Increased oxygen consumption
  • Rapid development of hypoxemia
  • Left lateral tilt or manual displacement of the uterus after 20 weeks gestation 1

The mortality for ARDS remains high (30-45%) and increases with the severity of hypoxemia 1, 4. Early implementation of lung-protective ventilation strategies and appropriate adjunctive therapies is crucial to improve outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.